MedTrace Logo

Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome

NCT02089620 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2015-08-11

No results posted yet for this study

Summary

Premenstrual syndrome represents a group of problems affecting most of women in reproductive age. These problems include emotional and physical symptoms. In this study the efficacy of oral contraceptive pills and calcium supplements in relieving these symptoms will be assessed .

Conditions

  • Premenstrual Syndrome

Interventions

DRUG

Yasmin

will be used every 21 days for three months by the patient

DIETARY_SUPPLEMENT

Calver

Calver will be given daily for 3 months

DRUG

Placebo 1

Patients will receive a daily placebo similar in size and structure to calvar.

DRUG

Placebo 2

Women will receive an oral placebo similar to COC for 21 days starting from the 3rd day of menstruation

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Nesreen A Shehata, Lecturer · Beni-Suef University

  • Abdelgany M Hassan, Lecturer · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02089620 on ClinicalTrials.gov